Page 9 - Oezlem Tuereci News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oezlem tuereci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oezlem Tuereci Today - Breaking & Trending Today

BioNTech founders warn of vaccine supply gaps


BioNTech founders warn of vaccine supply gaps - Spiegel
Reuters
1/1/2021
Says testing BioNTech/Pfizer vaccine on UK COVID variant
Says could tweak vaccine for strong mutations in 6 weeks
BioNTech may have more easily storable vaccine by summer
By Douglas Busvine
BERLIN, Jan 1 (Reuters) - BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union due to relatively slow approval from the bloc s health regulator and the small size of the order placed by Brussels. ....

United States , United Kingdom , Bruxelles Capitale , John Stonestreet , Douglas Busvine , Oezlem Tuereci , Jens Spahn , Ugur Sahin , German Health , European Union , European Medicines Agency , Oxford University , Health Minister Jens Spahn , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , ஜான் ஸ்தோனேஸ்ற்ரீட் , ஜென்ஸ் ஸ்பான் , ஜெர்மன் ஆரோக்கியம் , ஐரோப்பிய தொழிற்சங்கம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆரோக்கியம் அமைச்சர் ஜென்ஸ் ஸ்பான் ,

BioNTech says it can't ramp up production fast enough to fill demand for coronavirus vaccine


Last Updated Friday, January 1, 2021 12:50PM EST
BERLIN, Jan 1 (Reuters) BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union because of relatively late approval from the bloc s health regulator and the small size of the order placed by Brussels.
The delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within days of starting an inoculation drive. ....

United States , United Kingdom , Bruxelles Capitale , Oezlem Tuereci , Jens Spahn , Ugur Sahin , German Health , European Union , European Medicines Agency , Oxford University , Health Minister Jens Spahn , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , ஜென்ஸ் ஸ்பான் , ஜெர்மன் ஆரோக்கியம் , ஐரோப்பிய தொழிற்சங்கம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆரோக்கியம் அமைச்சர் ஜென்ஸ் ஸ்பான் ,

BioNTech Founders Warn of Covid-19 Vaccine Supply Gaps


BioNTech Founders Warn of Covid-19 Vaccine Supply Gaps
FOLLOW US ON:
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union due to relatively slow approval from the bloc’s health regulator and the small size of the order placed by Brussels.
The delays have caused consternation in Germany, where some regions had to temporarily close vaccination centres days after the launch of an inoculation drive on December 27. ....

United States , United Kingdom , Bruxelles Capitale , Oezlem Tuereci , Jens Spahn , Ugur Sahin , German Health , European Union , European Medicines Agency , Oxford University , Health Minister Jens Spahn , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , ஜென்ஸ் ஸ்பான் , ஜெர்மன் ஆரோக்கியம் , ஐரோப்பிய தொழிற்சங்கம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆரோக்கியம் அமைச்சர் ஜென்ஸ் ஸ்பான் ,

COVID: BioNTech founders warn of vaccine supply gaps


BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders have said, warning there would be gaps in supply until other vaccines were rolled out.
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union due to relatively slow approval from the bloc’s health regulator and the small size of the order placed by Brussels.
The delays have caused consternation in Germany, where some regions had to temporarily close vaccination centres days after the launch of an inoculation drive on December 27. ....

United States , United Kingdom , Bruxelles Capitale , Oezlem Tuereci , Jens Spahn , Ugur Sahin , German Health , European Union , European Medicines Agency , Oxford University , Der Spiegel , Health Minister Jens Spahn , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , ஜென்ஸ் ஸ்பான் , ஜெர்மன் ஆரோக்கியம் , ஐரோப்பிய தொழிற்சங்கம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , டெர் ஸ்பீகல் , ஆரோக்கியம் அமைச்சர் ஜென்ஸ் ஸ்பான் ,